SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+3.7%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$77M
AUM Growth
+$77M
(+167%)
Cap. Flow
+$44.1M
Cap. Flow
% of AUM
57.26%
Top 10 Holdings %
Top 10 Hldgs %
76.76%
Holding
105
New
31
Increased
5
Reduced
14
Closed
38
Top Buys
| 1 |
Biogen
BIIB
|
$27.8M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
$7.09M |
| 3 |
Moderna
MRNA
|
$4.62M |
| 4 |
Xeris Biopharma Holdings
XERS
|
$2.89M |
| 5 |
PLLL
Piedmont Lithium Limited American Depositary Receipts
PLLL
|
$2.88M |
Top Sells
| 1 |
SPDR Gold Trust
GLD
|
$2.66M |
| 2 |
Enlivex Therapeutics
ENLV
|
$2.18M |
| 3 |
NOVN
Novan, Inc. Common Stock
NOVN
|
$2.11M |
| 4 |
Outlook Therapeutics
OTLK
|
$1.94M |
| 5 |
Pluri
PLUR
|
$1.44M |
Sector Composition
| 1 | Healthcare | 73.93% |
| 2 | Industrials | 1.66% |
| 3 | Consumer Discretionary | 0.57% |
| 4 | Financials | 0.41% |
| 5 | Consumer Staples | 0.29% |